Clinical trial

Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)

NCT07171684

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-11-26

PhaseNA

Study timeline

Study start (actual)2025-11-26Date precision: day

Registry last updated2026-04-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes in Pregnancyunresolved

Gestational Diabetesunresolved

Interventions

Insulin glargine aloneDRUG

Insulin glargine + insulin lisproDRUG

Sponsors & collaborators

Rutgers, The State University of New Jerseylead sponsor

NYU Langone Healthcollaborator

Mapped research locations

New YorkNew York, United States1 New BrunswickNew Jersey, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07171684 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.